Nov 5, 2025 08:55AM Anixa Biosciences signs data transfer deal with Cleveland Clinic

Oct 20, 2025 08:25AM Anixa Biosciences (ANIX) Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology

Sep 11, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Sep 8, 2025 08:01AM Anixa completes fourth cohort dosing in ovarian cancer CAR-T trial

Aug 12, 2025 08:06AM Anixa Biosciences receives new US patent for CAR-T technology

Jul 25, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Jul 24, 2025 08:03AM ANIXA Biosciences receives patent for breast cancer vaccine through 2040s

Jul 9, 2025 08:00AM Anixa Biosciences receives U.S. patent for ovarian cancer vaccine

Jun 25, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Jun 23, 2025 08:02AM Anixa Biosciences (ANIX) Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Jun 4, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Apr 9, 2025 08:03AM Anixa Biosciences (ANIX) Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

Mar 25, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Mar 24, 2025 08:04AM Anixa Biosciences (ANIX) Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Feb 18, 2025 08:07AM Anixa Biosciences (ANIX) Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Jan 21, 2025 08:33AM Anixa Biosciences (ANIX) CEO Provides Letter to Shareholders

Nov 22, 2024 08:16AM Anixa Biosciences (ANIX) Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Nov 19, 2024 06:58AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Nov 8, 2024 01:17PM Anixa Biosciences (ANIX) and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine

Sep 30, 2024 08:31AM Anixa Biosciences (ANIX) Submits Protocol Amendment for CAR-T Trial

Sep 24, 2024 08:31AM Anixa Biosciences (ANIX) Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Sep 17, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)

Aug 7, 2024 07:02AM EF Hutton Starts Anixa Biosciences (ANIX) at Buy

Jul 23, 2024 08:17AM Anixa Biosciences (ANIX) Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Jul 17, 2024 08:01AM Anixa Biosciences (ANIX) Announces Japanese Patent on Breast Cancer Vaccine Technology

Jul 15, 2024 08:30AM Anixa Biosciences (ANIX) Announces $5 Million Share Repurchase Program

Jun 24, 2024 08:46AM Anixa Biosciences (ANIX) Treats Sixth Patient in its Ovarian Cancer CAR-T Trial

Jun 10, 2024 05:39AM Anixa Biosciences (ANIX) PT Lowered to $7 at H.C. Wainwright